Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 10.89
-0.32 (-2.85%)
At close: Jan 16, 2026
Grifols Market Cap
Grifols has a market cap or net worth of €6.58 billion as of January 16, 2026. Its market cap has increased by 12.04% in one year.
Market Cap
6.58B
Enterprise Value
17.81B
Revenue
7.52B
Ranking
n/a
PE Ratio
19.91
Stock Price
€10.89
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 6.58B, an increase of 802.86%. That is a compound annual growth rate of 11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 6.58B | 0.67% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 3.58B |
| Almirall | 2.84B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.42B |
| Clínica Baviera | 813.41M |
| Oryzon Genomics | 259.82M |
| Atrys Health | 229.14M |
| Prim, S.A. | 226.31M |